Website Changes
10/22/2011
Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.
10/22/2011
The challenges of managing glioblastoma multiforme in developing countries: a trade-off between cost and qu ality of care.
10/21/2011
"The Legacy Brain Foundation is hosting their 5th annual "STARS COME OUT" event
this weekend, October 22, 2011, at the famous III Forks Steakhouse in Dallas,
Texas, at 7 p.m.
10/17/2011
Celtic Pharma Announces Completion of Enrollment in Dose Tolerance Trial Evaluating XERECEPT® in Pediatric Patients with Primary and Metastatic Brain Tumors
10/10/2011
Porn Star With Cancer Diverts Donations to Children`s Hospital
10/10/2011
Chemotherapy reduced OS in children with low-grade glioma
10/10/2011
METASTASIZED BRAIN CANCER TREATED WITH ISORAY`S CESIUM-131
IN WORLD`S FIRST AT N.Y. PRESBYTERIAN/WEILL CORNELL MEDICAL CENTER
10/09/2011
"Radiation and Radiosurgery
for Brain Tumors" - free seminar in NJ Oct. 26th
10/05/2011
Changes in Bevacizumab (Avastin) Labeling
10/04/2011
09/29/2011
Multi-Session Gamma Knife Radiosurgery Gaining Traction in North America to Treat Patients With Cancers in Brain and Skull Base
09/29/2011
John Theurer Cancer Center Launches the Brain & Spine Institute
09/25/2011
DAVID S. ZOCCHI MEMORIAL GOLF OUTING NJ Oct 3!
09/25/2011
Release of Glutamate From Gliomas Sparks Seizures
09/25/2011
Swedish`s Ivy Brain Tumor Center Launches Two New Clinical Trials to Treat Brain Cancer
09/25/2011
Surgical Innovation: Brain Cancer Cells Glow with New Drug
09/24/2011
Noscapine inhibits tumor growth in TMZ-resistant gliomas.
09/24/2011
Isolation of a new cell population in the glioblastoma microenvironment.
09/21/2011
Emerging Technologies In Brain Cancer Therapy
09/20/2011
Free Art Workshop - NJ
09/19/2011
Breaching the Blood-Brain Barrier
09/17/2011
Long Island 5k Run Oct 1
09/17/2011
Clinical Trial Tests Investigational New Drug for Malignant Brain Tumors
09/17/2011
BRAINSTORM: A Dialogue and Education Series
NONMALIGNANT AND LOW-GRADE BRAIN TUMORS: SURVIVING AND THRIVING
MONDAY, SEPTEMBER 19, 2011 (NL)
09/16/2011
Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bev acizumab-induced Invasion in U87 Glioma.
which delivers brain tumor news and additions
to the website via RSS.